scholarly journals P2.23 First-Line Gefitinib in Epidermal Growth Factor Receptor Mutation-Positive (EGFR+) Non-Small Cell Lung Cancer (NSCLC) in an Israeli Cohort

2012 ◽  
Vol 23 ◽  
pp. v29
Author(s):  
S. Ben-Arieh ◽  
D. Urban ◽  
N. Maimon ◽  
R. Leibowitz-Amit ◽  
D. Keizman ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document